Loading organizations...
Capital Rx delivers transparent pharmacy benefit management (PBM) and unified health administration solutions. Its AI-powered enterprise platform integrates pharmacy, medical, vision, and dental benefits, streamlining healthcare workflows. The company redefines prescription drug programs with flat-fee pricing and full rebate pass-through, ensuring clear, efficient administration.
A.J. Loiacono co-founded Capital Rx around 2017, motivated by pervasive inefficiencies and hidden fees in drug pricing. Leveraging his pharmaceutical supply chain experience and prior success with Truveris, Loiacono sought a transparent, equitable model. His insight aimed to simplify processes, ensuring clear costs and benefits align with patient needs.
Capital Rx serves self-funded employers, health plans (commercial, Medicare, Medicaid), and benefit brokers/consultants. Its mission is to build a modern healthcare infrastructure prioritizing affordability, transparency, and member well-being. The company envisions integrated technology powering a seamless, responsible benefit experience, transforming healthcare delivery in the United States.
RxCapital has 2 tracked investments across 1 company. The latest tracked deal is $130.0M Series B in Rivus Pharmaceuticals in September 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 1, 2022 | Rivus Pharmaceuticals | $130.0M Series B | Derek Dirocco | Qiming Venture Partners, Bain Capital Life Sciences, BB Biotech, Longitude Capital, Medicxi |
| Jul 22, 2021 | Rivus Pharmaceuticals | $35.0M Series A | Longitude Capital, Medicxi | — |